#Africa

Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.

A South African study found that treating the virus within 48 hours or waiting up to two weeks led to comparable viral suppression rates.

Only HIV vax to show any efficacy prompted strong immune response in new study

A long-term study found that kidney transplants between people with HIV have high success rates.

A study conducted in Africa compared various cognitive outcomes between children with and without the virus.

“This is excellent news for all children living with HIV.”

Treating within hours—rather than the recommended weeks—of birth also prompts an improved immune response against the virus.

New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.

Genetic sequencing indicated that three samples from 1983 to 2001 were all part of a newly established subtype L of group M of the virus.

The rollout of antiretroviral treatment in this hard-hit region has apparently not lowered this group’s risk of acquiring HIV.

In theory, starting antiretrovirals quiets the immune system, leading more immune cells to become part of the inactive reservoir.

That is according to a meta-analysis including nearly 500 people.

Researchers gave the vaccine, previously studied in Thailand, to participants in South Africa.

A recent study allayed concerns that certain forms of birth control were associated with an increased risk of acquiring the virus.

Events are scheduled throughout September to raise awareness about hep B and HIV in these communities.

Listen up: This powerhouse from Cameroon offers everyone an intentional conversation about power, privilege and accountability.